Abiopharma

News list

Chao David Tsung-Hung 🟡 adjusted position in 0 shares (1 derivative) of WESTLAKE CORP (WLK) Transaction Date: Aug 08, 2026 | Filing ID: 341997

Full text

News bot Aug. 10, 2026, 5:52 p.m.
🔍 Chao David Tsung-Hung (Executive)

Company: WESTLAKE CORP (WLK)

Report Date: 2026-08-08
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 2,168
- Total shares sold: 2,168
- Total shares held: 19,423
Detailed Transactions and Holdings:
- Acquired 2,168 shares of Common Stock (Direct)
  Date: 2026-08-08 | Code: M | equity_swap_involved: false | shares_owned_after: 11,080.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-08 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 19,423.00 | Footnotes: F2
- Sold 2,168 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-08 | Code: M | equity_swap_involved: false | shares_owned_after: 2,168.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
Footnotes:
- F1: Restricted stock units convert into the Issuer's common stock on a one-for-one basis.
- F2: These shares are held in a trust for the benefit of the reporting person, who also serves as sole trustee.
- F3: On August 8, 2025 the reporting person was granted 2,168 restricted stock units vesting on the first anniversary of the grant date.